These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8406387)

  • 1. Lectin binding and expression of blood group-related antigens in carcinoma-in-situ and invasive carcinoma of urinary bladder.
    Nakanishi K; Kawai T; Suzuki M
    Histopathology; 1993 Aug; 23(2):153-8. PubMed ID: 8406387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on multiple mucosal biopsy in patients with bladder cancer. 4. Evaluation of Thomsen-Friedenreich antigen in multiple mucosal biopsy and transitional cell carcinoma of the bladder].
    Igawa M
    Hinyokika Kiyo; 1986 Nov; 32(11):1663-76. PubMed ID: 3825815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of blood group surface antigens of urinary bladder tumours using monoclonal antibodies with the avidin-biotin complex technique.
    Tan LB; Chiang C; Huang CH; Lin LM
    Int Urol Nephrol; 1992; 24(3):255-64. PubMed ID: 1399382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Blood group isoantigen and lectin binding studies in the human bladder cancer].
    Yagi S
    Nihon Hinyokika Gakkai Zasshi; 1989 May; 80(5):682-90. PubMed ID: 2666700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of ABH antigenicity of random mucosal biopsies and transitional cell carcinoma of the urinary bladder.
    Jakse G; Hofstädter F
    Eur Urol; 1983; 9(2):97-101. PubMed ID: 6852091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
    Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
    J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive potential of superficial bladder cancer. A study of the relative merits of predictive parameters.
    Das G; Buxton NJ; Glashan RW
    Br J Urol; 1985 Feb; 57(1):32-6. PubMed ID: 3882180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histochemical study of lectin binding in neoplastic and non-neoplastic urothelium.
    Neal DE; Charlton RG; Bennett MK
    Br J Urol; 1987 Nov; 60(5):399-404. PubMed ID: 3322471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry and cytochemistry of experimental rat bladder cancer: binding of the lectins PNA and WGA and of a Le(Y) mouse monoclonal antibody.
    Langkilde NC; Hastrup J; Olsen S; Wolf H; Orntoft TF
    J Urol; 1989 Apr; 141(4):981-6. PubMed ID: 2926911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. Criteria for the loss of BGA based on the staining pattern by the PAP method and its correlation with CEA and fibronectin].
    Nasu Y
    Nihon Hinyokika Gakkai Zasshi; 1986 Jun; 77(6):977-87. PubMed ID: 3534405
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative study of peanut agglutinin and amaranthin binding to human urinary bladder tumor glycoproteins.
    Langkilde NC; Orntoft TF
    Scand J Urol Nephrol Suppl; 1995; 172():57-64. PubMed ID: 8578258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood group antigens in transitional cell tumours of the urinary bladder. An immunohistochemical study.
    Juhl BR
    Dan Med Bull; 1994 Feb; 41(1):1-11. PubMed ID: 8187557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualization of urothelial blood group isoantigens A and B using direct biotin-labeled antibodies and avidin-biotin-peroxidase complex.
    Lin CW; Fujime M; Kirley SD; Prout GR
    J Histochem Cytochem; 1984 Dec; 32(12):1139-43. PubMed ID: 6209329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Tn antigen with Vicia villosa agglutinin in urinary bladder cancer: its relevance to the patient's clinical course.
    Nishiyama T; Matsumoto Y; Watanabe H; Fujiwara M; Sato S
    J Natl Cancer Inst; 1987 Jun; 78(6):1113-8. PubMed ID: 3295352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lectinohistochemistry of human bladder cancer: loss of lectin binding structures in invasive carcinomas.
    Langkilde NC; Wolf H; Orntoft TF
    APMIS; 1989 Apr; 97(4):367-73. PubMed ID: 2719853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphometric and immunohistochemical characterization of bladder carcinoma in situ and its preneoplastic lesions.
    Sanchez-Fernandez de Sevilla MC; Morell-Quadreny L; Gil-Salom M; Perez-Bacete M; Llombart-Bosch A
    Eur Urol; 1992; 21 Suppl 1():5-9. PubMed ID: 1425837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prediction of invasive potential in superficial transitional cell carcinoma of the bladder.
    Finan PJ; Anderson JR; Doyle PT; Lennox ES; Bleehen NM
    Br J Urol; 1982 Dec; 54(6):720-5. PubMed ID: 6758916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lectin-binding sugar chain in bladder tumors].
    Sumiya H; Sato N; Isaka S; Shimazaki J; Matsuzaki O
    Hinyokika Kiyo; 1988 Jan; 34(1):86-9. PubMed ID: 3376809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of vascular endothelial growth factors A, C and D as indicators of lymphangiogenesis and angiogenesis in invasive and non-invasive urothelial carcinoma bladder.
    Khadim MT; Ahmed SA; Khan FA; Ikram A; Shaikh SY
    J Pak Med Assoc; 2015 Aug; 65(8):851-6. PubMed ID: 26228330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connective tissue stroma in bladder papillary transitional cell carcinoma, carcinoma in situ and benign cystitis.
    Ooms EC; Blomjous CE; Zwartendijk J; Veldhuizen RW; Blok AP; Heinhuis RJ; Boon ME
    Histopathology; 1986 Jun; 10(6):613-9. PubMed ID: 2426175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.